Huifeng Signs Agreement with DNP

XI’AN, China—Huifeng Bio-Pharmaceutical Technology Inc. (BB: HFGB) signed a major supply agreement with DNP International Co. Inc., Santa Fe Springs, Calif. Under terms of the agreement, Huifeng will supply 62 metric tons of glucuronolactone to DNP by the end of 2008; the contract totals more than USD $1.1 million. Huifeng anticipates signing additional bi-annual contracts with DNP upon successful completion of the first agreement.

“Our agreement with DNP further demonstrates the increasing international acceptance of Huifeng products,” said Jing’An Wang, CEO, Huifeng. “With quality and consistency as our hallmarks, we are now becoming recognized by major U.S. corporations for the quality and consistency of the products we develop and manufacture. We are pleased to be making further inroads into the U.S. market and hope to sign similar supply agreements with DNP and other U.S. entities in the near future.”